Page 11 - Vaccine

European nations impose incentives, penalties to boost Covid vaccine shots

Some business owners are uncomfortable with having to enforce the rules

Don't blame private sector

Vaccine distribution lags are because of state controls

Over 3 mn children in India missed out on first DTP-1 vax dose in 2020: WHO

Over 3 million children in India missed out on their first dose of diphtheria-tetanus-pertussis combined vaccine (DTP-1) in 2020, WHO said

Virus, variant and vaccines

The main worry is the price of vaccines, not production, says Sunita Narain

A bottleneck in the vaccine chain

Prosenjit Datta points to a possible crisis as the government moves to improve supplies of Covid vaccines: inadequate testing facilities to handle those volumes

Indian scientists working on developing mRNA vaccine technology get grant

Ignite Life Science Foundation has awarded its first grant award for "pandemic preparedness" research to a team of researchers at the Indian Institute of Science (Bengaluru)

Why Centre 'conspicuously silent' on Brazil's Covaxin controversy: Congress

The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter

Two doses of Covid-19 vaccine give 98% protection, says PGI study

The study, which didn't spe­cify the name of the vacc­ine, was conducted on Pun­jab police personnel

Covid-19 vaccine estimate of 2 bn doses aspirational, optimistic: Govt

Inoculation drive is a marathon, not a 100-metre sprint, says health ministry

World's 'first' DNA vaccine against coronavirus: All you need to know

If things go well, ZyCoV-D could be the first approved vaccine for adolescents. The vaccine also works against the Delta variant, claims the company

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax

Decoded: Why Brazilian govt is under scrutiny over Bharat Biotech vaccine

The Brazilian media has reported that though Bharat Biotech initially quoted a price of $1.34 per dose, the Brazilian govt agreed to pay $15 per shot, having ignored Pfizer's offer at a lower price

Brazil suspends $324-mn Covid-19 vaccine deal with Bharat Biotech

The deal to buy 20 million doses of Bharat Biotech's Covaxin shot has become a headache for Bolsonaro after whistleblowers went public with alleged irregularities

Top headlines: India approves Moderna vaccine; Sebi announces reforms

Business Standard brings you the top news of the evening

Sanofi to invest 400 million euros in mRNA vaccines development

The mRNA technology has proven both effective and safe so far in the vaccine response to COVID-19, including in response to the virus' variants.

Covid-19 vaccination: Fear, myths & rumours inject vaccine hesitancy

Govts, NGOs and corporations try to get fence-sitters to take the jab

Odisha govt to launch Pneumococcal Conjugate Vaccine on June 30

The Odisha Government on Thursday said that it will launch Pneumococcal Conjugate Vaccine (PCV) under the universal immunisation programme on June 30."The introduction of PCV in the routine immunization will benefit nearly 8 lakh young children annually in the State and it will help in reducing the risk of morbidity and mortality due to pneumonia and meningitis among children in the State", said the additional Chief Secretary PK Mohapatra in a letter to district and municipal authorities."Inviting in reference to the subject cited above, I am to say that Minister, Health & Family Welfare will launch Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Programme on 30th June 2021 at 11.30 AM at State level through virtual mode. After the introduction of PCV in the Routine Immunization, it will benefit nearly 8 lakh young children annually in our State and this will help in reducing risk of morbidity & mortality due to Pneumonia and meningitis among children in .

A jab at veracity

States should not aim to artificially push vaccination numbers

Bharat Biotech's Covaxin shows over 77% efficacy in phase 3 trials

The vaccine has shown an efficacy rate of 93 per cent against severe disease and 60 per cent against asymptomatic Covid-19

Coronavirus LIVE: Record 1.32 million vaccinated in a single day in Andhra

Coronavirus unlock live updates: India on Sunday reported 58,419 new Covid-19 cases and 1,576 deaths from the disease. Stay tuned for corona-related updates.